3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Melanoma
1
HIV Infections
1
Adenoviridae Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cell Count
2
tretazicar
1
fludarabine
1
enadenotucirev
1
Vaccines
1
Tumor Necrosis Factor-alpha
1
Radiotherapy
1
Interferon-beta
1
Genetic Engineering
1
Endostatins
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Adenoviridae Infections
×
Tumor Necrosis Factor-alpha
×
Clear all
NCT04695327
2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1
Completed
32 enrolled